Keywords: akzo, nobel, divest, diosynth, site, organon, human

Akzo Nobel to divest Diosynth site

Article | 16 May 2005

Print This

Organon, the human health care business of Dutch firm Akzo Nobel, has announced its intention to divest its Diosynth manufacturing ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in